Table 1. Comparison of the clinical characteristics of patients with stage IE–IIE1 or IIE2–IV POALs.
| Stage I–IIE1 | Stage IIE2–IV | P | |
|---|---|---|---|
| Number of patients | 91 | 16 | |
| Age at diagnosis | 0.248 | ||
| Median | 57 | 65.5 | |
| Range | 22–102 | 29–84 | |
| Sex | 0.872 | ||
| Male | 48 | 10 | |
| Female | 43 | 6 | |
| Orbital laterality | 0.904 | ||
| Right | 41 | 8 | |
| Left | 34 | 4 | |
| Bilateral | 16 | 4 | |
| Location | 0.980 | ||
| Orbital | 40 | 9 | |
| Conjunctiva | 39 | 3 | |
| Lacrimal gland | 12 | 4 | |
| Pathology | 0.468 | ||
| MALT lymphoma | 80 | 13 | |
| DLBCL(MALT) | 4 | 1 | |
| DLBCL | 7 | 2 |
Abbreviations: POALs, primary ocular adnexal lymphomas; MALT, mucosa-associated lymphoid tissue; DLBCL, diffuse large B-cell lymphoma; DLBCL(MALT), DLBCL with histologic evidence of MALT lymphoma by WHO classification.